We showed that the inhibition of menin, with either small molecule MIs or genetic knockdown, led to increases in LXR-target gene expression, including the cholesterol exporters ABCG1 and ABCA1, in multiple CRC cell lines. The gene discussed is MEN1; the disease is colorectal carcinoma.